McFarlane Neil F. — SEC Form 4 filings
SEC reporting owner CIK 1681098. 8 Form 4 filings on record with FilingPulse; latest filed 2026-02-10.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-02 to 2026-02-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 4 filings — 216,942 shares, $1,916,909 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 91,000 shares @ $9.38 ($853,425) in ZEVRA THERAPEUTICS, INC., filed 2026-02-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. (ZVRA) | President and CEO, Director | 7 | — | 5 legs · 216,942 sh · $1,916,909 | 13 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | Director | 1 | — | — | 1 |
Form 4 filings — McFarlane Neil F.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-10 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Option exercise (M): 37,500 · Sale (S): 14,625 @ $8.56 · Option exercise (M): 37,500 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Option exercise (M): 233,334 · Sale (S): 91,000 @ $9.38 · Grant/award (A): 125,000 (derivative) @ $0 · Grant/award (A): 250,000 (derivative) @ $0 · Option exercise (M): 233,334 (derivative) @ $0 | EDGAR |
| 2025-10-10 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Option exercise (M): 50,000 · Sale (S): 19,500 @ $10.82 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Sale (S): 61,273 @ $7.86 · Sale (S): 30,544 @ $8.05 | EDGAR |
| 2025-02-10 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Grant/award (A): 225,000 (derivative) @ $0 · Grant/award (A): 112,500 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Option exercise (M): 233,333 · Option exercise (M): 233,333 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/award (A): 7,693 @ $0 | EDGAR |
| 2024-02-02 | 4 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1681098 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →